XTL Biopharmaceuticals Ltd. (XTLB)
$2.63-5.40%Close
SELLRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $6M
- Avg volume
- 84.0K
- Beta
- 0.46
- P/E (TTM)
- -0.83
- Short % float
- 1.06%
- Days to cover
- 7.0
- SI change
- -32.1%
- 1W
- +1.15%
- 1M
- -10.54%
- 3M
- +4.78%
- YTD
- +9.58%
- vs SPY 1W
- +2.34%
- vs SPY 1M
- -13.87%
- vs SPY 3M
- +2.39%
- vs SPY YTD
- -2.17%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- OTLKSELLOutlook Therapeutics, Inc.CRISISQ -14$0.61-6.15%
- CELZBUYCreative Medical Technology Holdings, Inc.RECOVERYQ -9$1.21-7.63%
- NSPRBUYInspireMD, Inc.RECOVERYQ -24$0.87-3.33%
- VERUBUYVeru Inc.RECOVERYQ 8$2.59-1.89%
- HCWBSELLHCW Biologics Inc.CRISISQ -20$2.31+5.96%
- MLSSBUYMilestone Scientific Inc.BEARQ 5$0.47-2.08%
- OCULBUYOcular Therapeutix, Inc.RECOVERYQ 5$10.78-2.71%
- KTTABUYPasithea Therapeutics Corp.RECOVERYQ -20$0.51-5.56%
- SNYRSELLSynergy CHC Corp.CRISISQ 1$0.10+0.00%
- BUDZBUYWEED, Inc.CRISISQ 2$0.03+0.00%
- PVCTSELLProvectus Biopharmaceuticals, Inc.RECOVERYQ 2$0.06+0.00%
- STLNBUYBULLQ 4$6.13-5.26%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 10
- VALUE
- 5
- GROWTH
- 35
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-161.4%
REV YoY-
ROE-269.0%
EPS YoY-
ROA-
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.83
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B-23.51
P/FCF-
EV/EBITDA-5.13
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.40
ND/EBITDA-
BETA0.46
